Although C-reactive protein (CRP) is often used to assess inflammation and can predict high blood pressure (BP) and arterial stiffness, novel measures of inflammation derived from platelets, white blood cell counts, and high-density lipoprotein cholesterol (HDL-C) may also indicate possible hypertension and arterial stiffening. This evidence concerns the gene CRP and hypertensive disorder.